CS
BCAB icon

Candriam SCA’s BioAtla BCAB Stock Holding History

Candriam SCA’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31,308
Closed -$3.86M – 737
2023
Q1 		$3.86M Sell
31,308
-4,800
-13% -$865K 0.03% 421
2022
Q4 		$14.9M Sell
36,108
-2,100
-5% -$871K 0.1% 203
2022
Q3 		$14.7M Buy
38,208
+30,567
+400% +$10M 0.1% 205
2022
Q2 		$1.09M Hold
7,641
– – 0.01% 612
2022
Q1 		$1.91M Sell
7,641
-452
-6% -$189K 0.01% 551
2021
Q4 		$7.94M Hold
8,093
– – 0.05% 293
2021
Q3 		$11.9M Buy
8,093
+5,501
+212% +$10.7M 0.08% 243
2021
Q2 		$5.49M Buy
+2,592
New +$5.86M 0.04% 387

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return